Using the electronic health records of over 5 million people aged under 30, researchers from the Oxford Health Biomedical Research Centre found that eating disorders were diagnosed significantly more commonly in 2020 than in previous years, with the rate increasing steadily throughout the year. This new research, published in the British Journal of Psychiatry, shows…
News
Ground-breaking treatment offers new hope for patients with persecutory delusions
Feeling Safe is a new treatment programme for persecutory delusions, which promises a step change in the treatment of severe mental health problems. The clinical trial results show that the new Feeling Safe programme is the most effective psychological treatment for persecutory delusions, with 50 percent of patients achieving recovery from their persecutory delusions. Persecutory…
New Senior Research Fellows named
Academic-Industry Meeting day (AIMday) launches new experimental medicine industry hub
Researchers at Oxford Health BRC have created a new hub to foster collaboration with industry in the field of experimental medicine, helping to accelerate the rate at which new treatments can begin to benefit patients. The Experimental Medicine Industry Partnership (EMIP) will provide a framework through which BRC researchers can use their expertise to support…
Oxford Health BRC wins government funding for its CHRONOS project
Treating needle fears may reduce COVID-19 vaccine hesitancy rates by 10%
A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia. Strikingly, these individuals were twice as likely to report that they were COVID-19 vaccine hesitant – that is, they would put off getting vaccinated or indeed never get the jab. The study indicates that if all injection anxiety in the population was removed then just over 10% of instances of vaccine hesitancy might disappear too.
